<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02912208</url>
  </required_header>
  <id_info>
    <org_study_id>Eqol_MDS</org_study_id>
    <nct_id>NCT02912208</nct_id>
  </id_info>
  <brief_title>Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes</brief_title>
  <official_title>Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes (EQol-MDS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Associazione Qol-one</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Associazione Qol-one</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myelodysplastic syndromes (MDS) prevail in older age and are characterized by ineffective
      erythropoiesis and peripheral cytopenias. Supportive therapy is the main therapeutic option
      for most patients. Quality of Life (QoL) is mainly deteriorated by anemia and by the
      limitations associated with thrombocytopenia, neutropenia and transfusion dependence. The
      only available treatment for severe thrombocytopenia, in the presence of bleeding, is
      platelet transfusion.

      Eltrombopag is an orally bioavailable agonist of the thrombopoietin receptor. In adult
      patients with chronic immune thrombocytopenia (ITP), Eltrombopag rapidly increases platelet
      counts and significantly reduces bleeding episodes during treatment. Eltrombopag is well
      tolerated. In 2007, Eltrombopag has received the Orphan Drug Designation for the treatment of
      ITP (EMEA/OD/031/07), and in 2008 the Food and Drug Association approved Eltrombopag for the
      treatment of ITP refractory or resistant. It has been shown that in patients affected by MDS
      and by acute myeloid leukemia, Eltrombopag neither increases the proliferation, nor the
      clonogenic growth capacity of bone marrow blasts. Furthermore, Eltrombopag induces an
      increase in the megakaryocytic differentiation and in the formation of normal megakaryocytic
      colonies. These results provide the rationale for pursuing further research on Eltrombopag
      for the treatment of thrombocytopenia in case of MDS.

      The study is open to adult patients with myelodysplastic syndrome (MDS) with thrombocytopenia
      and low- or intermediate-1 IPSS risk (Index Prognostic Score System).

      Severe thrombocytopenia associated with MDS may lead to death from hemorrhage, even in low
      prognostic risk patients. The benefit of platelet transfusion is short-termed. Patients
      become refractory in the long term. The availability of a treatment that induces the increase
      of platelet count is extremely important, either in terms of quality of life, and in overall
      survival.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Response rate</measure>
    <time_frame>Six months</time_frame>
    <description>Proportion of patients achieving a complete response (CR) or response (R) during the treatment period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety and Tolerability (number of adverse events)</measure>
    <time_frame>Six month</time_frame>
    <description>Safety and tolerability in terms of frequency of adverse events (AE) and serious adverse events (SAE)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of platelet response</measure>
    <time_frame>five years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>long-term safety and tolerability (number adverse events in the long term)</measure>
    <time_frame>five years</time_frame>
    <description>Number of participants with treatment-related adverse events as assessed by CTCAE v4.0 and number of adverse events reporting in accordance with CTCAE v4.0</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life (QoL) score</measure>
    <time_frame>six months</time_frame>
    <description>to evaluate the changes of the quality of life in the two arms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of monthly platelet transfusions</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>duration of transfusion independence</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to response</measure>
    <time_frame>six months</time_frame>
    <description>time to response (time from starting treatment to time of achievement of CR or PR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence and severity of bleeding</measure>
    <time_frame>six months</time_frame>
    <description>incidence and severity of bleeding using the WHO (World Health Organization)Bleeding Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>2 and 5 years</time_frame>
    <description>overall survival (OS) at 2 and at 5 years</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>leukemia-free survival (LFS)</measure>
    <time_frame>2 and 5 years</time_frame>
    <description>leukemia-free survival (LFS) at 2 and at 5 years (events for LFS are defined as death and progression to AML);</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">174</enrollment>
  <condition>Myelodysplastic Syndromes</condition>
  <condition>Thrombocytopenia</condition>
  <arm_group>
    <arm_group_label>Arm 1 (Eltrombopag)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm 1 is the active treatment arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2 (Placebo)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Arm 2 is the control arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Eltrombopag/Revolade</intervention_name>
    <description>Eltrombopag 50 mg once daily has been selected as the starting dose for this study. Thereafter, dependent on platelet response the dose of study medication can be increased by 50 mg every 2 weeks, up to a maximum dose of 300 mg once daily (150 mg in subjects of East Asian ethnicity).</description>
    <arm_group_label>Arm 1 (Eltrombopag)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The administration is the same of eltrombopag</description>
    <arm_group_label>Arm 2 (Placebo)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult subjects (18 years of age or older) with low or intermediate-1 IPSS risk MDS and
             stable disease.

          2. Subjects must have a platelet count taken within the 4 weeks prior to randomization
             that is &lt;30 Gi/L.

          3. Subjects must be ineligible or relapsed or refractory to receive other treatment
             options (such as azacitidine or lenalidomide) and must be ineligible to receive
             intensive chemotherapy or autologous/allogeneic stem cell transplantation.

          4. Subjects must have platelet count and platelet transfusion data available over a
             period of 8 weeks prior to randomization.

          5. During the 2 months prior to randomization, subjects must have a baseline Bone Marrow
             examination which includes cytomorphology and cytogenetics. Histopathology should be
             performed.

          6. Erythropoiesis-stimulating agents (ESAs) in anemic subjects or granulocyte
             colonystimulating factor (G-CSF) in subjects with severe neutropenia and recurrent
             infections are allowed during the study as per accepted standards. Subjects who enter
             the study on ESAs or G-CSF should continue at the same dose schedule until the optimal
             dose of study medication has been established.

          7. ECOG (Eastern Cooperative Oncology Group) Performance Status 0-3

          8. Subject is able to understand and comply with protocol requirements and instructions.

          9. Subject has signed and dated informed consent.

         10. Adequate baseline organ function defined by the criteria below:

             total bilirubin (except for Gilbert's Syndrome) ≤ 1.5 x Upper Limit Normal Alanine
             aminotransferase and Aspartate aminotransferase ≤ 3 x Upper Limit Normal creatinine ≤
             2 x Upper Limit Normal albumin must not be below the lower limit of normal by more
             than 20%.

         11. Subject is practicing an acceptable method of contraception. Female subjects (or
             female partners of male subjects) must either be of non-childbearing potential
             (hysterectomy, bilateral oophorectomy, bilateral tubal ligation or post-menopausal &gt;1
             year), or of childbearing potential and use of an highly effective method of
             contraception from 2 weeks prior to administration of study medication, throughout the
             study, and 28 days after completion or premature discontinuation from the study.

        Exclusion Criteria:

          1. MDS with intermediate-2 or high IPSS risk.

          2. History of treatment for cancer other than MDS with systemic chemotherapy and/or
             radiotherapy within the last 2 years.

          3. History of treatment with romiplostim or other Thrombopoietin receptor agonists.

          4. Pre-existing cardiovascular disease (including congestive heart failure, New York
             Heart Association Grade III/IV), or arrhythmia known to increase the risk of
             thromboembolic events (e.g. persistent atrial fibrillation), or subjects with a QTc
             &gt;450 msec (QTc &gt;480 msec for subjects with Bundle Branch Block).

          5. BM fibrosis that leads to an inability to aspirate marrow for assessment.

          6. Peripheral monocytosis &gt; 1000/uL prior to Day 1 of study medication.

          7. Leukocytosis &gt;=25,000/uL prior to Day 1 of study medication.

          8. Female subjects who are nursing or pregnant (positive serum or urine Beta-human
             chorionic gonadotropin [B-hCG] pregnancy test) at screening or pre-dose on Day 1.

          9. Current alcohol or drug abuse.

         10. Treatment with an Investigational Product within 30 days or 5 half-lives (whichever is
             longer) preceding the first dose of study medication.

         11. Active and uncontrolled infections.

         12. Subjects infected with Hepatitis B, C or Human Immunodeficiency Virus (HIV).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esther Natalie Oliva</last_name>
    <role>Study Chair</role>
    <affiliation>QOL-ONE Associazione Culturale e di Ricerca</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Esther Natalie Oliva</last_name>
    <phone>+39 3297978204</phone>
    <email>qolone@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Giuseppe Iannì</last_name>
    <phone>+39 3336589725</phone>
    <email>ianni@dielnet.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bérengère Gruson</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre d'Avignon</name>
      <address>
        <city>Avignon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bohrane Slama</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Côte Basque</name>
      <address>
        <city>Bayonne</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bauduer Frédéric</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre d'Avicenne, Hôpital d'Avicenne</name>
      <address>
        <city>Bobigny</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thosten Braun</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Haut-Lévèque</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sophie Dimicoli-Salazar</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Boulogne Sur Mer</name>
      <address>
        <city>Boulogne Sur Mer</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Benoit De Renzis</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Clémenceau</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stéphane Cheze</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrea Toma</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Grenoble</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Park</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Le Mans</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kamel Laribi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Vincent de Paul</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Rose</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Limoges</name>
      <address>
        <city>Limoges</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dominique Bordessoule</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de Marseille</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Norbert Vey</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Brabois</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnes Guerci-Bresler</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacques Delaunay</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Archet 1</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurence Legros</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Nimes</name>
      <address>
        <city>Nimes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Jourdan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de St Louis, Hôpital St Louis</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Fenaux</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de la Région d'Annecy</name>
      <address>
        <city>Pringy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pascale Cony-Makhoul</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de Rouen, Centre Henri Becquerel</name>
      <address>
        <city>Rouen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aspasia Stamatoullas</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Purpan</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Odile Beyne-Rauzy</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Bretonneau</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Gyan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Heinrich-Heine-Universität Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Germing</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Mannheim</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Florian Nolte</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O. SS. Antonio e Biagio e Cesare Arrigo</name>
      <address>
        <city>Alessandria</city>
        <state>AL</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Flavia Salvi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Riuniti</name>
      <address>
        <city>Ancona</city>
        <state>AN</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonella Poloni</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Cardinal Massaia</name>
      <address>
        <city>Asti</city>
        <state>AT</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monia Marchetti</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O. S. Giovanni Moscati</name>
      <address>
        <city>Avellino</city>
        <state>AV</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Volpe</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Università di Bari</name>
      <address>
        <city>Bari</city>
        <state>BA</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giorgina Specchia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale A. Perrino</name>
      <address>
        <city>Brindisi</city>
        <state>BR</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Angela Melpignano</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;Roberto Binaghi&quot;</name>
      <address>
        <city>Cagliari</city>
        <state>CA</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Caocci</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero Oncologico Businco</name>
      <address>
        <city>Cagliari</city>
        <state>CA</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emanuele Angelucci</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale L'Annunziata</name>
      <address>
        <city>Cosenza</city>
        <state>CS</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fortunato Morabito</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Ferrarotto</name>
      <address>
        <city>Catania</city>
        <state>CT</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Di Raimondo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Garibaldi</name>
      <address>
        <city>Catania</city>
        <state>CT</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefana Impera</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Casa Sollievo della Sofferenza</name>
      <address>
        <city>San Giovanni Rotondo</city>
        <state>FG</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Cascavilla</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Università degli Studi di Genova</name>
      <address>
        <city>Genova</city>
        <state>GE</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrico Balleari</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <state>LE</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Di Renzo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O. San Gerardo</name>
      <address>
        <city>Monza</city>
        <state>MB</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lorenza Borin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agostino Cortelezzi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Niguarda</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfredo Molteni</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico Paolo Giaccone</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Maria Enza Mitra</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Riuniti Villa Sofia - Cervello</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Ospedali Riuniti - P.O. Cervello</name>
      <address>
        <city>Palermo</city>
        <state>PA</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aurelio Di Maggio</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile Spirito Santo</name>
      <address>
        <city>Pescara</city>
        <state>PE</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Di Bartolomeo</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <state>PI</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Bianchi-Melacrino-Morelli</name>
      <address>
        <city>Reggio Calabria</city>
        <state>RC</state>
        <zip>89100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Esther Oliva</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arcispedale di Santa Maria Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <state>RE</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Avanzini</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O. San Camillo Forlanini</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano Mancini</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Sant'Eugenio</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pasquale Niscola</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Agostino Gemelli</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luana Fianchi</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Università Campus Bio Medico di Roma</name>
      <address>
        <city>Roma</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Giuseppe Avvisati</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Sant'Andrea</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto Regina Elena</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Atelda Romano</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale Nuova Regina Margherita</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Andriani</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Umberto I</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuliana Alimena</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Universitario Tor Vergata</name>
      <address>
        <city>Rome</city>
        <state>RM</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Buccisano</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O.U. San Giovanni di Dio e Ruggì D'Aragona</name>
      <address>
        <city>Salerno</city>
        <state>SA</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Carmine Selleri</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Policlinico Santa Maria alle Scotte</name>
      <address>
        <city>Siena</city>
        <state>SI</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Bocchia</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O. Santa Maria</name>
      <address>
        <city>Terni</city>
        <state>TE</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Marina Liberati</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>A.O. Citta' della Salute e della Scienza di Torino</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dario Ferrero</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>U.O. Citta' della Salute e della Scienza di Torino</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bernardino Allione</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedale San Bortolo</name>
      <address>
        <city>Vicenza</city>
        <state>VI</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Rodeghiero</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Careggi</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valeria Santini</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>General Hospital Celje</name>
      <address>
        <city>Celje</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Univerzitetni klinini center Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Maribor</name>
      <address>
        <city>Maribor</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>General Hospital Murska Sobota</name>
      <address>
        <city>Murska Sobota</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>General Hospital Nova Gorica</name>
      <address>
        <city>Nova Gorica</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>General Hospital Novo mesto</name>
      <address>
        <city>Novo Mesto</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>General Hospital Slovenj Gradec</name>
      <address>
        <city>Slovenj Gradec</city>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2016</study_first_submitted>
  <study_first_submitted_qc>September 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2016</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Myelodysplastic Syndromes</mesh_term>
    <mesh_term>Preleukemia</mesh_term>
    <mesh_term>Thrombocytopenia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

